About us
What we do
Our strategy
Market opportunity
Our team
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Financial calendar
Shareholder information
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Share price
INC 04.75 GBp
About us
What we do
Our strategy
Market opportunity
Our team
Board of Directors
Senior Management
Advisors and Founders
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Share price chart
Detailed share price
Financial calendar
Shareholder information
Shareholder Information
AGM
GM
Analyst coverage
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Corporate Governance Report
QCA Corporate Governance Principles
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Latest from Incanthera
Home
News & media
Latest from Incanthera
Latest from Incanthera
2025
2024
2023
Archive
June 19th, 2020
Initiation of research - Preparing Sol for commercialisation
View
June 15th, 2020
Incanthera plc: Results for the year ended 31 March 2020
View
June 15th, 2020
Incanthera says it's making great progress towards commercialisation of lead skin cancer asset
View
June 15th, 2020
Incanthera says it is delighted with first results since IPO
View
June 15th, 2020
Incanthera Update Profile
June 10th, 2020
Incanthera eyes huge market for cancer-prevention suncream
View
Prev
2
3
4
Next